State Street
THRD

State Street’s Third Harmonic Bio THRD Stock Holding History

State Street’s Portfolio THRD Stock Details THRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-468,994
Closed -$2.55M – 4374
2025
Q2 		$2.55M Buy
468,994
+34,466
+8% +$172K ﹤0.01% 3224
2025
Q1 		$1.51M Buy
434,528
+12,690
+3% +$61.5K ﹤0.01% 3336
2024
Q4 		$4.34M Buy
421,838
+21,301
+5% +$265K ﹤0.01% 3035
2024
Q3 		$5.43M Buy
400,537
+14,662
+4% +$182K ﹤0.01% 2927
2024
Q2 		$5.02M Buy
385,875
+5,488
+1% +$67.9K ﹤0.01% 2929
2024
Q1 		$3.59M Buy
380,387
+50,285
+15% +$489K ﹤0.01% 3059
2023
Q4 		$3.62M Buy
330,102
+51,969
+19% +$412K ﹤0.01% 3096
2023
Q3 		$1.78M Buy
278,133
+13,430
+5% +$82.1K ﹤0.01% 3376
2023
Q2 		$1.27M Buy
264,703
+46,073
+21% +$219K ﹤0.01% 3546
2023
Q1 		$901K Buy
218,630
+24,200
+12% +$103K ﹤0.01% 3565
2022
Q4 		$836K Buy
+194,430
New +$3.25M ﹤0.01% 3601

Other funds holding THRD

Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
CF
Cantor Fitzgerald New York $6.78B AUM 29.01% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return
JC
JBF Capital Aspen, Colorado $676M AUM 24.74% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
AB
Amalgamated Bank New York $13.1B AUM 29.66% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
Optiver Holding
Optiver Holding Amsterdam, Netherlands $289B AUM 33.63% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

State Street's THRD Position: Q3 2025 in Review

State Street sold out of Third Harmonic Bio (THRD) in Q3 2025, closing a stake of 468,994 shares — an estimated $2.55M sold.

State Street first reported a position in THRD in Q4 2022 and held it in 11 quarters. The position peaked at $5.43M in Q3 2024. 18 funds tracked by Wall St. Rank hold THRD as of Q3 2025.

  • State Street reported no remaining Third Harmonic Bio position as of Q3 2025 after selling out during the quarter.
  • State Street sold 468,994 Third Harmonic Bio shares in Q3 2025, an estimated $2.55M.
  • State Street first reported a position in Third Harmonic Bio in Q4 2022 and held it in 11 quarters.
  • State Street's Third Harmonic Bio position peaked at $5.43M in Q3 2024.
  • 18 funds tracked by Wall St. Rank held Third Harmonic Bio as of Q3 2025.

Based on State Street's 13F filing for Q3 2025, filed 14 Nov 2025.